| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 6,076,935 | 6,963,931 | 7,365,588 | 6,843,145 | | Cost of Revenue | 4,488,524 | 5,033,473 | 4,966,384 | 4,608,879 | | | Gross Profit | 1,588,411 | 1,930,458 | 2,399,204 | 2,234,266 | | | Operating Expenses | | Research Development | 189,516 | 222,218 | 208,168 | 197,374 | | Selling General and Administrative | 151,359 | 173,669 | 172,268 | 172,001 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,247,536 | 1,534,571 | 2,018,768 | 1,864,891 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,247,536 | 1,534,571 | 2,018,768 | 1,864,891 | | Interest Expense | 55,072 | 58,709 | 61,148 | 61,354 | | Income Before Tax | 1,192,464 | 1,475,862 | 1,957,620 | 1,803,537 | | Income Tax Expense | 252,079 | 325,664 | 418,142 | 377,731 | | Minority Interest |
-
| (58) | (13,116) | (5,811) | | | | Net Income From Continuing Ops | 940,385 | 1,150,140 | 1,526,362 | 1,419,995 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 940,385 | 1,150,140 | 1,526,362 | 1,419,995 | | Preferred Stock And Other Adjustments | (1,924) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $938,461 | $1,150,140 | $1,526,362 | $1,419,995 |
|
0.45% Nasdaq 
0.20%
Income Statement
